Mangrove Partners’s Pfizer PFE Stock Holding History

Mangrove Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-33,105	Closed	-$844K	–	422
2025 Q3	$844K	Buy	+33,105	New	+$817K	0.06%	130
2025 Q1	–	Sell	-42,718	Closed	-$1.13M	–	198
2024 Q4	$1.13M	Buy	+42,718	New	+$1.16M	0.13%	69

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Mangrove Partners's PFE Position: Q4 2025 in Review

Mangrove Partners sold out of Pfizer (PFE) in Q4 2025, closing a stake of 33,105 shares — an estimated $844K sold.

Mangrove Partners first reported a position in PFE in Q4 2024 and held it in 2 quarters. The position peaked at $1.13M in Q4 2024. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

Mangrove Partners reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
Mangrove Partners sold 33,105 Pfizer shares in Q4 2025, an estimated $844K.
Mangrove Partners first reported a position in Pfizer in Q4 2024 and held it in 2 quarters.
Mangrove Partners's Pfizer position peaked at $1.13M in Q4 2024.
2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Mangrove Partners's 13F filing for Q4 2025, filed 17 Feb 2026.